Pengfei Wang Selected Research

iron phthalocyanine

1/2022

Iron phthalocyanine-derived nanozyme as dual reactive oxygen species generation accelerator for photothermally enhanced tumor catalytic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pengfei Wang Research Topics

Disease

107	Neoplasms (Cancer) 04/2024 - 10/2004
48	Infections 02/2024 - 01/2002
21	COVID-19 02/2024 - 01/2020
10	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2019
9	Breast Neoplasms (Breast Cancer) 01/2024 - 09/2006
9	Diarrhea 04/2023 - 01/2017
9	Inflammation (Inflammations) 01/2023 - 12/2016
8	Hemorrhage 01/2023 - 02/2002
8	Sepsis (Septicemia) 03/2022 - 09/2009
7	Cognitive Dysfunction 08/2022 - 05/2013
6	Stomach Neoplasms (Stomach Cancer) 04/2024 - 09/2013
6	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 09/2006
5	Shock 04/2024 - 09/2008
5	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2024 - 11/2015
5	Wounds and Injuries (Trauma) 10/2023 - 09/2008
5	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2023 - 08/2017
5	Hypoxia (Hypoxemia) 01/2023 - 03/2018
5	Hemorrhagic Shock 01/2015 - 09/2008
4	Virus Diseases (Viral Diseases) 04/2024 - 01/2021
4	Ovarian Epithelial Carcinoma 04/2024 - 06/2020
4	Renal Cell Carcinoma (Grawitz Tumor) 03/2024 - 01/2008
4	Ischemic Stroke 03/2024 - 08/2022
4	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 01/2023
4	Pain (Aches) 12/2023 - 09/2021
4	Parkinson Disease (Parkinson's Disease) 11/2023 - 01/2015
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 07/2009
4	Bacterial Infections (Bacterial Infection) 12/2022 - 03/2018
4	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 01/2016
4	Glioma (Gliomas) 01/2021 - 01/2016
3	Precocious Puberty 05/2024 - 07/2021
3	Colonic Neoplasms (Colon Cancer) 04/2024 - 01/2023
3	Sarcopenia 04/2024 - 01/2018
3	Breakthrough Infections 12/2023 - 10/2022
3	Phototoxic Dermatitis (Phototoxicity) 11/2023 - 02/2010
3	Melanoma (Melanoma, Malignant) 11/2023 - 09/2006
3	Stroke (Strokes) 11/2023 - 08/2016
3	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 01/2022
3	Neuroinflammatory Diseases 03/2023 - 12/2020
3	Enteritis 01/2023 - 10/2018
3	Colitis 01/2023 - 11/2008
3	Insulin Resistance 11/2022 - 08/2020
3	Carcinoma (Carcinomatosis) 06/2022 - 10/2004
3	Reperfusion Injury 04/2022 - 01/2021
3	Brain Edema (Cerebral Edema) 04/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 05/2024 - 10/2004
18	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2023 - 02/2010
17	MicroRNAs (MicroRNA)IBA 03/2024 - 01/2018
16	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2017
13	RNA (Ribonucleic Acid)IBA 01/2024 - 06/2015
12	Messenger RNA (mRNA)IBA 07/2022 - 05/2012
11	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2011
10	Monoclonal AntibodiesIBA 02/2024 - 10/2004
10	VaccinesIBA 12/2023 - 09/2014
10	Long Noncoding RNAIBA 11/2023 - 01/2018
10	CytokinesIBA 01/2023 - 09/2008
8	EnzymesIBA 05/2024 - 04/2007
8	AntibodiesIBA 02/2024 - 09/2013
8	Photosensitizing Agents (Photosensitizers)IBA 01/2023 - 06/2017
8	Interleukin-6 (Interleukin 6)IBA 01/2023 - 09/2008
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018 - 09/2008
7	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 01/2019
6	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2018
6	CarbonIBA 01/2024 - 01/2016
6	NF-kappa B (NF-kB)IBA 01/2023 - 11/2008
6	Therapeutic UsesIBA 01/2023 - 11/2008
6	AlbuminsIBA 06/2022 - 01/2018
5	Small Interfering RNA (siRNA)IBA 02/2024 - 11/2015
5	Antiviral Agents (Antivirals)IBA 02/2024 - 12/2021
5	Neuroprotective AgentsIBA 01/2024 - 05/2013
5	Transcription Factors (Transcription Factor)IBA 11/2023 - 05/2008
5	Singlet OxygenIBA 01/2023 - 03/2018
5	NitrogenIBA 01/2022 - 01/2008
5	hypocrellin AIBA 12/2021 - 12/2018
5	ChemokinesIBA 01/2021 - 01/2019
5	Ringer's LactateIBA 04/2014 - 03/2009
4	Neutralizing AntibodiesIBA 12/2023 - 01/2019
4	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2023 - 01/2018
4	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2023 - 01/2022
4	Oxygen (Dioxygen)IBA 07/2021 - 05/2009
4	Starch (Cornstarch)IBA 02/2010 - 03/2009
3	Hemoglobins (Hemoglobin)IBA 04/2024 - 01/2022
3	Indicators and Reagents (Reagents)IBA 03/2024 - 01/2022
3	Immunoglobulin G (IgG)IBA 12/2023 - 10/2019
3	AntigensIBA 11/2023 - 09/2014
3	IronIBA 11/2023 - 01/2022
3	Antimicrobial PeptidesIBA 09/2023 - 11/2019
3	Phosphotransferases (Kinase)IBA 07/2023 - 07/2009
3	Caspase 3 (Caspase-3)IBA 01/2023 - 05/2013

Therapy/Procedure

58	Therapeutics 04/2024 - 10/2004
16	Photochemotherapy (Photodynamic Therapy) 01/2024 - 01/2016
12	Photothermal Therapy 04/2024 - 06/2017
10	Drug Therapy (Chemotherapy) 01/2023 - 07/2016
8	Precision Medicine 01/2024 - 01/2016
6	Immunotherapy 11/2023 - 01/2017
4	Phototherapy (Light Therapy) 05/2023 - 06/2017
4	Lasers (Laser) 01/2023 - 01/2015
4	Length of Stay 01/2023 - 01/2021
4	Resuscitation 04/2014 - 03/2009
3	Gastrectomy 04/2024 - 01/2018
3	Intraperitoneal Injections 11/2022 - 09/2016